MMA Asset Management’s Biogen BIIB Stock Holding History

MMA Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-600	Closed	-$84K	–	194
2025 Q3	$84K	Buy	+600	New	+$81.1K	0.03%	194
2024 Q2	–	Sell	-500	Closed	-$108K	–	133
2024 Q1	$108K	Buy	+500	New	+$117K	0.05%	131

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MMA Asset Management's BIIB Position: Q4 2025 in Review

MMA Asset Management sold out of Biogen (BIIB) in Q4 2025, closing a stake of 600 shares — an estimated $84K sold.

MMA Asset Management first reported a position in BIIB in Q1 2024 and held it in 2 quarters. The position peaked at $108K in Q1 2024. 1,000 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

MMA Asset Management reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
MMA Asset Management sold 600 Biogen shares in Q4 2025, an estimated $84K.
MMA Asset Management first reported a position in Biogen in Q1 2024 and held it in 2 quarters.
MMA Asset Management's Biogen position peaked at $108K in Q1 2024.
1,000 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on MMA Asset Management's 13F filing for Q4 2025, filed 3 Feb 2026.